Produit
AGENTS IA
APPLICATIONS DE L'IA
AUTRES
Solutions
SECTEURS D'ACTIVITÉ
USE CASES
Tarification
Ressources
EXPLORER
ENGAGER
ASSISTANCE ET SERVICES
À propos
Plateforme PatSnap Eureka
Mandataires en propriété intellectuelle
Agents pour l'ingénierie
Agents pour les sciences de la vie
Agents pour matériaux
PatSnap Eureka Desktop
NEWAnalytique
Intelligence IPSynapse
Renseignement biopharmaceutiqueBiographie
Recherche et analyse de séquences biologiquesChimique
Recherche et analyse de structures chimiquesPlateforme ouverte
NEWServices professionnels
Cabinets d'avocats
Sciences de la vie
Haute technologie
Competitor Tech Research
Design Risk Screening
Cosmetic Formulation
Telecom SEP Claim Chart
Accès à plus de 2 000 000 000 points de données structurées dans les domaines des brevets, des sciences, des litiges et des technologies.
Innovez 75 % plus vite à un coût réduit de 25 %.
Cloud ou sur site pour une confidentialité et un contrôle maximaux
Reconnu par plus de 18 000 innovateurs à travers le monde
Pour l'utiliser, cliquez sur le bouton de vérification dans l'e-mail que nous avons envoyé à [email protected].
Cela contribue à sécuriser votre compte.
Vous devriez le recevoir sous peu. N'oubliez pas de vérifier votre dossier spam.
Unlock professional features and history
Already have an account? Log In
To start using PatSnap Eureka, click the verification button in the email we sent to .
This helps keep your account secure.
Haven't received it? Check your spam folder.
Série soigneusement sélectionnée offrant des informations précieuses aux professionnels de l'innovation.
Article | Rapport How sodium channel modulators, potassium channel openers, and gene therapy are reshaping the epilepsy drug pipeline for refractory and rare genetic epilepsies.
Article | Rapport How sodium channel modulators, potassium channel openers, and gene therapy are reshaping the epilepsy drug pipeline for refractory and rare genetic seizure disorders.
Article | Rapport Explore the ADHD drug pipeline: non-stimulant mechanisms, extended-release formulations, and adult ADHD approaches — from mGluR activators to KDM1A inhibitors.
Article | Rapport How sparse attention mechanisms cut transformer inference costs by eliminating O(n²) bottlenecks. Patent-backed analysis of masking, token compression & more.
Article | Rapport Survey of non-opioid CLBP drug pipeline: anti-NGF antibodies, central sensitization targets, dual biologics, and emerging nucleic acid approaches. 12 modalities mapped.
Article | Rapport How neuromorphic computing architecture cuts energy in always-on sensor processing: event-driven SNNs, sparsity exploitation, in-memory compute, and 2000× power savings explained.
Article | Rapport Survey of non-opioid CLBP drug pipeline: anti-NGF antibodies, centralized pain mechanisms, dual-target biologics, and emerging nucleic acid approaches. Patent intelligence from PatSnap.
Article | Rapport How to improve TIM performance between power dies and heat spreaders in AI server modules — patent-backed strategies from Intel, Google, Tesla, IBM and more.
Article | Rapport How to improve TIM performance between power dies and heat spreaders in AI server modules — patent strategies from Intel, Google, Tesla, IBM, and Laird.
Article | Rapport Explore the OSA drug pipeline: hypoglossal nerve stimulation, GLP-1 receptor agonists, NRI combinations, and arousal threshold approaches reshaping sleep apnea treatment.
Article | Rapport Engineering a 10GW offshore wind HVDC transmission system: converter topology, MVDC collection grids, black-start capability, and submarine cable corridor planning examined through patent data.
Article | Rapport Explore the AF drug pipeline: rhythm control agents, novel antiarrhythmics, gene therapy, and precision pharmacology shaping atrial fibrillation treatment.
Article | Rapport How AI, Bayesian optimization, LLMs, and robotics are accelerating electrolyte formulation discovery for next-generation lithium batteries. Patent analysis by PatSnap.
Article | Rapport Myosin inhibitors, gene therapy, and RNA-targeting strategies are reshaping the non-obstructive HCM drug pipeline. Explore the patent signals and clinical evidence.
Article | Rapport DBC vs AMB substrates for SiC power modules: compare bonding chemistry, CTE mismatch, thermal conductivity, and reliability data from 50+ patent sources.